How blood vessels adapt to high blood pressure: A new discovery
Researchers uncover how endothelial cells sense and respond to loss of function, offering insights into vascular health and potential new treatments for hypertension
Immunotherapy before surgery shows promise for esophageal cancer
New study by researchers at The Institute finds improved survival and potential for personalized treatment
First patient in Canada receives mRNA-based bladder cancer treatment in clinical trial at the MUHC
The investigational therapy combines mRNA technology with immunotherapy...
New study finds that COVID-19 boosters help avoid breakthrough infections in immunocompromised people
Researchers focused on those with rheumatoid arthritis, lupus...
D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer
Three members of The Institute are among recipients of D2R funding to support their groundbreaking...
Researchers honored with King Charles III's Coronation Medal for outstanding achievements
In recognition of their contributions to the understanding of neurological and respiratory disease, four members...
Inaugural Research Canada Innovates event at The Institute a resounding success
Sold-out event united health researchers and innovators to shape the future of healthcare
Experts from the McGill International TB Centre and The Institute publish a prestigious Lancet seminar on TB
Commissioned work underscores the role of tuberculosis (TB) as a leading...
Final winners announced in inaugural Networks competition
Three interdisciplinary teams awarded funding to launch innovative research networks at The Institute
Epinephrine could reduce hospitalizations in pediatric intensive care after a severe allergic reaction
Research confirms the use of epinephrine before arrival at the...